Global Quadrivalent Flu Vaccine Market Insights, Forecast to 2029
This report presents an overview of global market for Quadrivalent Flu Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Quadrivalent Flu Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Quadrivalent Flu Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Quadrivalent Flu Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Quadrivalent Flu Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Quadrivalent Flu Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi Pasteur, AstraZeneca, CSL, Abbott and GlaxoSmithKline, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Quadrivalent Flu Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Quadrivalent Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Quadrivalent Flu Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
This report researches the key producers of Quadrivalent Flu Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Quadrivalent Flu Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Quadrivalent Flu Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Quadrivalent Flu Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Quadrivalent Flu Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi Pasteur, AstraZeneca, CSL, Abbott and GlaxoSmithKline, etc.
By Company
- Sanofi Pasteur
- AstraZeneca
- CSL
- Abbott
- GlaxoSmithKline
- Intramuscular Injection
- Nasal Spray
- Intradermal Shot
- Hospital
- Clinic
- Public Health Agency
- Other
- US & Canada
- U.S.
- Canada
- China
- Asia (excluding China)
- Japan
- South Korea
- China Taiwan
- Southeast Asia
- India
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Middle East, Africa, Latin America
- Brazil
- Mexico
- Turkey
- Israel
- GCC Countries
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Quadrivalent Flu Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Quadrivalent Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Quadrivalent Flu Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 STUDY COVERAGE
1.1 Quadrivalent Flu Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Quadrivalent Flu Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Intramuscular Injection
1.2.3 Nasal Spray
1.2.4 Intradermal Shot
1.3 Market by Application
1.3.1 Global Quadrivalent Flu Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Public Health Agency
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Quadrivalent Flu Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Quadrivalent Flu Vaccine Revenue by Region
2.2.1 Global Quadrivalent Flu Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Quadrivalent Flu Vaccine Revenue by Region (2018-2023)
2.2.3 Global Quadrivalent Flu Vaccine Revenue by Region (2024-2029)
2.2.4 Global Quadrivalent Flu Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Quadrivalent Flu Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Quadrivalent Flu Vaccine Sales by Region
2.4.1 Global Quadrivalent Flu Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Quadrivalent Flu Vaccine Sales by Region (2018-2023)
2.4.3 Global Quadrivalent Flu Vaccine Sales by Region (2024-2029)
2.4.4 Global Quadrivalent Flu Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Quadrivalent Flu Vaccine Sales by Manufacturers
3.1.1 Global Quadrivalent Flu Vaccine Sales by Manufacturers (2018-2023)
3.1.2 Global Quadrivalent Flu Vaccine Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Quadrivalent Flu Vaccine in 2022
3.2 Global Quadrivalent Flu Vaccine Revenue by Manufacturers
3.2.1 Global Quadrivalent Flu Vaccine Revenue by Manufacturers (2018-2023)
3.2.2 Global Quadrivalent Flu Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Quadrivalent Flu Vaccine Revenue in 2022
3.3 Global Key Players of Quadrivalent Flu Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Quadrivalent Flu Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Quadrivalent Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Quadrivalent Flu Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Quadrivalent Flu Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Quadrivalent Flu Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Quadrivalent Flu Vaccine Sales by Type
4.1.1 Global Quadrivalent Flu Vaccine Historical Sales by Type (2018-2023)
4.1.2 Global Quadrivalent Flu Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Quadrivalent Flu Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Quadrivalent Flu Vaccine Revenue by Type
4.2.1 Global Quadrivalent Flu Vaccine Historical Revenue by Type (2018-2023)
4.2.2 Global Quadrivalent Flu Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Quadrivalent Flu Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Quadrivalent Flu Vaccine Price by Type
4.3.1 Global Quadrivalent Flu Vaccine Price by Type (2018-2023)
4.3.2 Global Quadrivalent Flu Vaccine Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Quadrivalent Flu Vaccine Sales by Application
5.1.1 Global Quadrivalent Flu Vaccine Historical Sales by Application (2018-2023)
5.1.2 Global Quadrivalent Flu Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Quadrivalent Flu Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Quadrivalent Flu Vaccine Revenue by Application
5.2.1 Global Quadrivalent Flu Vaccine Historical Revenue by Application (2018-2023)
5.2.2 Global Quadrivalent Flu Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Quadrivalent Flu Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Quadrivalent Flu Vaccine Price by Application
5.3.1 Global Quadrivalent Flu Vaccine Price by Application (2018-2023)
5.3.2 Global Quadrivalent Flu Vaccine Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Quadrivalent Flu Vaccine Market Size by Type
6.1.1 US & Canada Quadrivalent Flu Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Quadrivalent Flu Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Quadrivalent Flu Vaccine Market Size by Application
6.2.1 US & Canada Quadrivalent Flu Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Quadrivalent Flu Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Quadrivalent Flu Vaccine Market Size by Country
6.3.1 US & Canada Quadrivalent Flu Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Quadrivalent Flu Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Quadrivalent Flu Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Quadrivalent Flu Vaccine Market Size by Type
7.1.1 Europe Quadrivalent Flu Vaccine Sales by Type (2018-2029)
7.1.2 Europe Quadrivalent Flu Vaccine Revenue by Type (2018-2029)
7.2 Europe Quadrivalent Flu Vaccine Market Size by Application
7.2.1 Europe Quadrivalent Flu Vaccine Sales by Application (2018-2029)
7.2.2 Europe Quadrivalent Flu Vaccine Revenue by Application (2018-2029)
7.3 Europe Quadrivalent Flu Vaccine Market Size by Country
7.3.1 Europe Quadrivalent Flu Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Quadrivalent Flu Vaccine Sales by Country (2018-2029)
7.3.3 Europe Quadrivalent Flu Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Quadrivalent Flu Vaccine Market Size
8.1.1 China Quadrivalent Flu Vaccine Sales (2018-2029)
8.1.2 China Quadrivalent Flu Vaccine Revenue (2018-2029)
8.2 China Quadrivalent Flu Vaccine Market Size by Application
8.2.1 China Quadrivalent Flu Vaccine Sales by Application (2018-2029)
8.2.2 China Quadrivalent Flu Vaccine Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Quadrivalent Flu Vaccine Market Size by Type
9.1.1 Asia Quadrivalent Flu Vaccine Sales by Type (2018-2029)
9.1.2 Asia Quadrivalent Flu Vaccine Revenue by Type (2018-2029)
9.2 Asia Quadrivalent Flu Vaccine Market Size by Application
9.2.1 Asia Quadrivalent Flu Vaccine Sales by Application (2018-2029)
9.2.2 Asia Quadrivalent Flu Vaccine Revenue by Application (2018-2029)
9.3 Asia Quadrivalent Flu Vaccine Sales by Region
9.3.1 Asia Quadrivalent Flu Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Quadrivalent Flu Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Quadrivalent Flu Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Company Information
11.1.2 Sanofi Pasteur Overview
11.1.3 Sanofi Pasteur Quadrivalent Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Sanofi Pasteur Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Pasteur Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Quadrivalent Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 AstraZeneca Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 CSL
11.3.1 CSL Company Information
11.3.2 CSL Overview
11.3.3 CSL Quadrivalent Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 CSL Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CSL Recent Developments
11.4 Abbott
11.4.1 Abbott Company Information
11.4.2 Abbott Overview
11.4.3 Abbott Quadrivalent Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Abbott Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abbott Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Quadrivalent Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 GlaxoSmithKline Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Quadrivalent Flu Vaccine Industry Chain Analysis
12.2 Quadrivalent Flu Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Quadrivalent Flu Vaccine Production Mode & Process
12.4 Quadrivalent Flu Vaccine Sales and Marketing
12.4.1 Quadrivalent Flu Vaccine Sales Channels
12.4.2 Quadrivalent Flu Vaccine Distributors
12.5 Quadrivalent Flu Vaccine Customers
13 MARKET DYNAMICS
13.1 Quadrivalent Flu Vaccine Industry Trends
13.2 Quadrivalent Flu Vaccine Market Drivers
13.3 Quadrivalent Flu Vaccine Market Challenges
13.4 Quadrivalent Flu Vaccine Market Restraints
14 KEY FINDINGS IN THE GLOBAL QUADRIVALENT FLU VACCINE STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Quadrivalent Flu Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Quadrivalent Flu Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Intramuscular Injection
1.2.3 Nasal Spray
1.2.4 Intradermal Shot
1.3 Market by Application
1.3.1 Global Quadrivalent Flu Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Public Health Agency
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Quadrivalent Flu Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Quadrivalent Flu Vaccine Revenue by Region
2.2.1 Global Quadrivalent Flu Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Quadrivalent Flu Vaccine Revenue by Region (2018-2023)
2.2.3 Global Quadrivalent Flu Vaccine Revenue by Region (2024-2029)
2.2.4 Global Quadrivalent Flu Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Quadrivalent Flu Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Quadrivalent Flu Vaccine Sales by Region
2.4.1 Global Quadrivalent Flu Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Quadrivalent Flu Vaccine Sales by Region (2018-2023)
2.4.3 Global Quadrivalent Flu Vaccine Sales by Region (2024-2029)
2.4.4 Global Quadrivalent Flu Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Quadrivalent Flu Vaccine Sales by Manufacturers
3.1.1 Global Quadrivalent Flu Vaccine Sales by Manufacturers (2018-2023)
3.1.2 Global Quadrivalent Flu Vaccine Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Quadrivalent Flu Vaccine in 2022
3.2 Global Quadrivalent Flu Vaccine Revenue by Manufacturers
3.2.1 Global Quadrivalent Flu Vaccine Revenue by Manufacturers (2018-2023)
3.2.2 Global Quadrivalent Flu Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Quadrivalent Flu Vaccine Revenue in 2022
3.3 Global Key Players of Quadrivalent Flu Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Quadrivalent Flu Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Quadrivalent Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Quadrivalent Flu Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Quadrivalent Flu Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Quadrivalent Flu Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Quadrivalent Flu Vaccine Sales by Type
4.1.1 Global Quadrivalent Flu Vaccine Historical Sales by Type (2018-2023)
4.1.2 Global Quadrivalent Flu Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Quadrivalent Flu Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Quadrivalent Flu Vaccine Revenue by Type
4.2.1 Global Quadrivalent Flu Vaccine Historical Revenue by Type (2018-2023)
4.2.2 Global Quadrivalent Flu Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Quadrivalent Flu Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Quadrivalent Flu Vaccine Price by Type
4.3.1 Global Quadrivalent Flu Vaccine Price by Type (2018-2023)
4.3.2 Global Quadrivalent Flu Vaccine Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Quadrivalent Flu Vaccine Sales by Application
5.1.1 Global Quadrivalent Flu Vaccine Historical Sales by Application (2018-2023)
5.1.2 Global Quadrivalent Flu Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Quadrivalent Flu Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Quadrivalent Flu Vaccine Revenue by Application
5.2.1 Global Quadrivalent Flu Vaccine Historical Revenue by Application (2018-2023)
5.2.2 Global Quadrivalent Flu Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Quadrivalent Flu Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Quadrivalent Flu Vaccine Price by Application
5.3.1 Global Quadrivalent Flu Vaccine Price by Application (2018-2023)
5.3.2 Global Quadrivalent Flu Vaccine Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Quadrivalent Flu Vaccine Market Size by Type
6.1.1 US & Canada Quadrivalent Flu Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Quadrivalent Flu Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Quadrivalent Flu Vaccine Market Size by Application
6.2.1 US & Canada Quadrivalent Flu Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Quadrivalent Flu Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Quadrivalent Flu Vaccine Market Size by Country
6.3.1 US & Canada Quadrivalent Flu Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Quadrivalent Flu Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Quadrivalent Flu Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Quadrivalent Flu Vaccine Market Size by Type
7.1.1 Europe Quadrivalent Flu Vaccine Sales by Type (2018-2029)
7.1.2 Europe Quadrivalent Flu Vaccine Revenue by Type (2018-2029)
7.2 Europe Quadrivalent Flu Vaccine Market Size by Application
7.2.1 Europe Quadrivalent Flu Vaccine Sales by Application (2018-2029)
7.2.2 Europe Quadrivalent Flu Vaccine Revenue by Application (2018-2029)
7.3 Europe Quadrivalent Flu Vaccine Market Size by Country
7.3.1 Europe Quadrivalent Flu Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Quadrivalent Flu Vaccine Sales by Country (2018-2029)
7.3.3 Europe Quadrivalent Flu Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Quadrivalent Flu Vaccine Market Size
8.1.1 China Quadrivalent Flu Vaccine Sales (2018-2029)
8.1.2 China Quadrivalent Flu Vaccine Revenue (2018-2029)
8.2 China Quadrivalent Flu Vaccine Market Size by Application
8.2.1 China Quadrivalent Flu Vaccine Sales by Application (2018-2029)
8.2.2 China Quadrivalent Flu Vaccine Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Quadrivalent Flu Vaccine Market Size by Type
9.1.1 Asia Quadrivalent Flu Vaccine Sales by Type (2018-2029)
9.1.2 Asia Quadrivalent Flu Vaccine Revenue by Type (2018-2029)
9.2 Asia Quadrivalent Flu Vaccine Market Size by Application
9.2.1 Asia Quadrivalent Flu Vaccine Sales by Application (2018-2029)
9.2.2 Asia Quadrivalent Flu Vaccine Revenue by Application (2018-2029)
9.3 Asia Quadrivalent Flu Vaccine Sales by Region
9.3.1 Asia Quadrivalent Flu Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Quadrivalent Flu Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Quadrivalent Flu Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Company Information
11.1.2 Sanofi Pasteur Overview
11.1.3 Sanofi Pasteur Quadrivalent Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Sanofi Pasteur Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Pasteur Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Quadrivalent Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 AstraZeneca Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 CSL
11.3.1 CSL Company Information
11.3.2 CSL Overview
11.3.3 CSL Quadrivalent Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 CSL Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CSL Recent Developments
11.4 Abbott
11.4.1 Abbott Company Information
11.4.2 Abbott Overview
11.4.3 Abbott Quadrivalent Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Abbott Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abbott Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Quadrivalent Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 GlaxoSmithKline Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Quadrivalent Flu Vaccine Industry Chain Analysis
12.2 Quadrivalent Flu Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Quadrivalent Flu Vaccine Production Mode & Process
12.4 Quadrivalent Flu Vaccine Sales and Marketing
12.4.1 Quadrivalent Flu Vaccine Sales Channels
12.4.2 Quadrivalent Flu Vaccine Distributors
12.5 Quadrivalent Flu Vaccine Customers
13 MARKET DYNAMICS
13.1 Quadrivalent Flu Vaccine Industry Trends
13.2 Quadrivalent Flu Vaccine Market Drivers
13.3 Quadrivalent Flu Vaccine Market Challenges
13.4 Quadrivalent Flu Vaccine Market Restraints
14 KEY FINDINGS IN THE GLOBAL QUADRIVALENT FLU VACCINE STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Quadrivalent Flu Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Intramuscular Injection
Table 3. Major Manufacturers of Nasal Spray
Table 4. Major Manufacturers of Intradermal Shot
Table 5. Global Quadrivalent Flu Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Quadrivalent Flu Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Quadrivalent Flu Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Quadrivalent Flu Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Quadrivalent Flu Vaccine Revenue Market Share by Region (2018-2023)
Table 10. Global Quadrivalent Flu Vaccine Revenue Market Share by Region (2024-2029)
Table 11. Global Quadrivalent Flu Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Quadrivalent Flu Vaccine Sales by Region (2018-2023) & (K Doses)
Table 13. Global Quadrivalent Flu Vaccine Sales by Region (2024-2029) & (K Doses)
Table 14. Global Quadrivalent Flu Vaccine Sales Market Share by Region (2018-2023)
Table 15. Global Quadrivalent Flu Vaccine Sales Market Share by Region (2024-2029)
Table 16. Global Quadrivalent Flu Vaccine Sales by Manufacturers (2018-2023) & (K Doses)
Table 17. Global Quadrivalent Flu Vaccine Sales Share by Manufacturers (2018-2023)
Table 18. Global Quadrivalent Flu Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Quadrivalent Flu Vaccine Revenue Share by Manufacturers (2018-2023)
Table 20. Global Key Players of Quadrivalent Flu Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 21. Quadrivalent Flu Vaccine Price by Manufacturers 2018-2023 (USD/Dose)
Table 22. Global Quadrivalent Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Quadrivalent Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quadrivalent Flu Vaccine as of 2022)
Table 24. Global Key Manufacturers of Quadrivalent Flu Vaccine, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Quadrivalent Flu Vaccine, Product Offered and Application
Table 26. Global Key Manufacturers of Quadrivalent Flu Vaccine, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Quadrivalent Flu Vaccine Sales by Type (2018-2023) & (K Doses)
Table 29. Global Quadrivalent Flu Vaccine Sales by Type (2024-2029) & (K Doses)
Table 30. Global Quadrivalent Flu Vaccine Sales Share by Type (2018-2023)
Table 31. Global Quadrivalent Flu Vaccine Sales Share by Type (2024-2029)
Table 32. Global Quadrivalent Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Quadrivalent Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Quadrivalent Flu Vaccine Revenue Share by Type (2018-2023)
Table 35. Global Quadrivalent Flu Vaccine Revenue Share by Type (2024-2029)
Table 36. Quadrivalent Flu Vaccine Price by Type (2018-2023) & (USD/Dose)
Table 37. Global Quadrivalent Flu Vaccine Price Forecast by Type (2024-2029) & (USD/Dose)
Table 38. Global Quadrivalent Flu Vaccine Sales by Application (2018-2023) & (K Doses)
Table 39. Global Quadrivalent Flu Vaccine Sales by Application (2024-2029) & (K Doses)
Table 40. Global Quadrivalent Flu Vaccine Sales Share by Application (2018-2023)
Table 41. Global Quadrivalent Flu Vaccine Sales Share by Application (2024-2029)
Table 42. Global Quadrivalent Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Quadrivalent Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Quadrivalent Flu Vaccine Revenue Share by Application (2018-2023)
Table 45. Global Quadrivalent Flu Vaccine Revenue Share by Application (2024-2029)
Table 46. Quadrivalent Flu Vaccine Price by Application (2018-2023) & (USD/Dose)
Table 47. Global Quadrivalent Flu Vaccine Price Forecast by Application (2024-2029) & (USD/Dose)
Table 48. US & Canada Quadrivalent Flu Vaccine Sales by Type (2018-2023) & (K Doses)
Table 49. US & Canada Quadrivalent Flu Vaccine Sales by Type (2024-2029) & (K Doses)
Table 50. US & Canada Quadrivalent Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 51. US & Canada Quadrivalent Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Quadrivalent Flu Vaccine Sales by Application (2018-2023) & (K Doses)
Table 53. US & Canada Quadrivalent Flu Vaccine Sales by Application (2024-2029) & (K Doses)
Table 54. US & Canada Quadrivalent Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 55. US & Canada Quadrivalent Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Quadrivalent Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Quadrivalent Flu Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 58. US & Canada Quadrivalent Flu Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Quadrivalent Flu Vaccine Sales by Country (2018-2023) & (K Doses)
Table 60. US & Canada Quadrivalent Flu Vaccine Sales by Country (2024-2029) & (K Doses)
Table 61. Europe Quadrivalent Flu Vaccine Sales by Type (2018-2023) & (K Doses)
Table 62. Europe Quadrivalent Flu Vaccine Sales by Type (2024-2029) & (K Doses)
Table 63. Europe Quadrivalent Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 64. Europe Quadrivalent Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Quadrivalent Flu Vaccine Sales by Application (2018-2023) & (K Doses)
Table 66. Europe Quadrivalent Flu Vaccine Sales by Application (2024-2029) & (K Doses)
Table 67. Europe Quadrivalent Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 68. Europe Quadrivalent Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Quadrivalent Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Quadrivalent Flu Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 71. Europe Quadrivalent Flu Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Quadrivalent Flu Vaccine Sales by Country (2018-2023) & (K Doses)
Table 73. Europe Quadrivalent Flu Vaccine Sales by Country (2024-2029) & (K Doses)
Table 74. China Quadrivalent Flu Vaccine Sales by Type (2018-2023) & (K Doses)
Table 75. China Quadrivalent Flu Vaccine Sales by Type (2024-2029) & (K Doses)
Table 76. China Quadrivalent Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 77. China Quadrivalent Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Quadrivalent Flu Vaccine Sales by Application (2018-2023) & (K Doses)
Table 79. China Quadrivalent Flu Vaccine Sales by Application (2024-2029) & (K Doses)
Table 80. China Quadrivalent Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 81. China Quadrivalent Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Quadrivalent Flu Vaccine Sales by Type (2018-2023) & (K Doses)
Table 83. Asia Quadrivalent Flu Vaccine Sales by Type (2024-2029) & (K Doses)
Table 84. Asia Quadrivalent Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 85. Asia Quadrivalent Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Quadrivalent Flu Vaccine Sales by Application (2018-2023) & (K Doses)
Table 87. Asia Quadrivalent Flu Vaccine Sales by Application (2024-2029) & (K Doses)
Table 88. Asia Quadrivalent Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 89. Asia Quadrivalent Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Quadrivalent Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Quadrivalent Flu Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 92. Asia Quadrivalent Flu Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Quadrivalent Flu Vaccine Sales by Region (2018-2023) & (K Doses)
Table 94. Asia Quadrivalent Flu Vaccine Sales by Region (2024-2029) & (K Doses)
Table 95. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Type (2018-2023) & (K Doses)
Table 96. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Type (2024-2029) & (K Doses)
Table 97. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 98. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Application (2018-2023) & (K Doses)
Table 100. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Application (2024-2029) & (K Doses)
Table 101. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Country (2018-2023) & (K Doses)
Table 107. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Country (2024-2029) & (K Doses)
Table 108. Sanofi Pasteur Company Information
Table 109. Sanofi Pasteur Description and Major Businesses
Table 110. Sanofi Pasteur Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 111. Sanofi Pasteur Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Sanofi Pasteur Recent Developments
Table 113. AstraZeneca Company Information
Table 114. AstraZeneca Description and Major Businesses
Table 115. AstraZeneca Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 116. AstraZeneca Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. AstraZeneca Recent Developments
Table 118. CSL Company Information
Table 119. CSL Description and Major Businesses
Table 120. CSL Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 121. CSL Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. CSL Recent Developments
Table 123. Abbott Company Information
Table 124. Abbott Description and Major Businesses
Table 125. Abbott Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 126. Abbott Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Abbott Recent Developments
Table 128. GlaxoSmithKline Company Information
Table 129. GlaxoSmithKline Description and Major Businesses
Table 130. GlaxoSmithKline Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 131. GlaxoSmithKline Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. GlaxoSmithKline Recent Developments
Table 133. Key Raw Materials Lists
Table 134. Raw Materials Key Suppliers Lists
Table 135. Quadrivalent Flu Vaccine Distributors List
Table 136. Quadrivalent Flu Vaccine Customers List
Table 137. Quadrivalent Flu Vaccine Market Trends
Table 138. Quadrivalent Flu Vaccine Market Drivers
Table 139. Quadrivalent Flu Vaccine Market Challenges
Table 140. Quadrivalent Flu Vaccine Market Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
Table 1. Global Quadrivalent Flu Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Intramuscular Injection
Table 3. Major Manufacturers of Nasal Spray
Table 4. Major Manufacturers of Intradermal Shot
Table 5. Global Quadrivalent Flu Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Quadrivalent Flu Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Quadrivalent Flu Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Quadrivalent Flu Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Quadrivalent Flu Vaccine Revenue Market Share by Region (2018-2023)
Table 10. Global Quadrivalent Flu Vaccine Revenue Market Share by Region (2024-2029)
Table 11. Global Quadrivalent Flu Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Quadrivalent Flu Vaccine Sales by Region (2018-2023) & (K Doses)
Table 13. Global Quadrivalent Flu Vaccine Sales by Region (2024-2029) & (K Doses)
Table 14. Global Quadrivalent Flu Vaccine Sales Market Share by Region (2018-2023)
Table 15. Global Quadrivalent Flu Vaccine Sales Market Share by Region (2024-2029)
Table 16. Global Quadrivalent Flu Vaccine Sales by Manufacturers (2018-2023) & (K Doses)
Table 17. Global Quadrivalent Flu Vaccine Sales Share by Manufacturers (2018-2023)
Table 18. Global Quadrivalent Flu Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Quadrivalent Flu Vaccine Revenue Share by Manufacturers (2018-2023)
Table 20. Global Key Players of Quadrivalent Flu Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 21. Quadrivalent Flu Vaccine Price by Manufacturers 2018-2023 (USD/Dose)
Table 22. Global Quadrivalent Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Quadrivalent Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quadrivalent Flu Vaccine as of 2022)
Table 24. Global Key Manufacturers of Quadrivalent Flu Vaccine, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Quadrivalent Flu Vaccine, Product Offered and Application
Table 26. Global Key Manufacturers of Quadrivalent Flu Vaccine, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Quadrivalent Flu Vaccine Sales by Type (2018-2023) & (K Doses)
Table 29. Global Quadrivalent Flu Vaccine Sales by Type (2024-2029) & (K Doses)
Table 30. Global Quadrivalent Flu Vaccine Sales Share by Type (2018-2023)
Table 31. Global Quadrivalent Flu Vaccine Sales Share by Type (2024-2029)
Table 32. Global Quadrivalent Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Quadrivalent Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Quadrivalent Flu Vaccine Revenue Share by Type (2018-2023)
Table 35. Global Quadrivalent Flu Vaccine Revenue Share by Type (2024-2029)
Table 36. Quadrivalent Flu Vaccine Price by Type (2018-2023) & (USD/Dose)
Table 37. Global Quadrivalent Flu Vaccine Price Forecast by Type (2024-2029) & (USD/Dose)
Table 38. Global Quadrivalent Flu Vaccine Sales by Application (2018-2023) & (K Doses)
Table 39. Global Quadrivalent Flu Vaccine Sales by Application (2024-2029) & (K Doses)
Table 40. Global Quadrivalent Flu Vaccine Sales Share by Application (2018-2023)
Table 41. Global Quadrivalent Flu Vaccine Sales Share by Application (2024-2029)
Table 42. Global Quadrivalent Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Quadrivalent Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Quadrivalent Flu Vaccine Revenue Share by Application (2018-2023)
Table 45. Global Quadrivalent Flu Vaccine Revenue Share by Application (2024-2029)
Table 46. Quadrivalent Flu Vaccine Price by Application (2018-2023) & (USD/Dose)
Table 47. Global Quadrivalent Flu Vaccine Price Forecast by Application (2024-2029) & (USD/Dose)
Table 48. US & Canada Quadrivalent Flu Vaccine Sales by Type (2018-2023) & (K Doses)
Table 49. US & Canada Quadrivalent Flu Vaccine Sales by Type (2024-2029) & (K Doses)
Table 50. US & Canada Quadrivalent Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 51. US & Canada Quadrivalent Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Quadrivalent Flu Vaccine Sales by Application (2018-2023) & (K Doses)
Table 53. US & Canada Quadrivalent Flu Vaccine Sales by Application (2024-2029) & (K Doses)
Table 54. US & Canada Quadrivalent Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 55. US & Canada Quadrivalent Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Quadrivalent Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Quadrivalent Flu Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 58. US & Canada Quadrivalent Flu Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Quadrivalent Flu Vaccine Sales by Country (2018-2023) & (K Doses)
Table 60. US & Canada Quadrivalent Flu Vaccine Sales by Country (2024-2029) & (K Doses)
Table 61. Europe Quadrivalent Flu Vaccine Sales by Type (2018-2023) & (K Doses)
Table 62. Europe Quadrivalent Flu Vaccine Sales by Type (2024-2029) & (K Doses)
Table 63. Europe Quadrivalent Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 64. Europe Quadrivalent Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Quadrivalent Flu Vaccine Sales by Application (2018-2023) & (K Doses)
Table 66. Europe Quadrivalent Flu Vaccine Sales by Application (2024-2029) & (K Doses)
Table 67. Europe Quadrivalent Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 68. Europe Quadrivalent Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Quadrivalent Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Quadrivalent Flu Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 71. Europe Quadrivalent Flu Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Quadrivalent Flu Vaccine Sales by Country (2018-2023) & (K Doses)
Table 73. Europe Quadrivalent Flu Vaccine Sales by Country (2024-2029) & (K Doses)
Table 74. China Quadrivalent Flu Vaccine Sales by Type (2018-2023) & (K Doses)
Table 75. China Quadrivalent Flu Vaccine Sales by Type (2024-2029) & (K Doses)
Table 76. China Quadrivalent Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 77. China Quadrivalent Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Quadrivalent Flu Vaccine Sales by Application (2018-2023) & (K Doses)
Table 79. China Quadrivalent Flu Vaccine Sales by Application (2024-2029) & (K Doses)
Table 80. China Quadrivalent Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 81. China Quadrivalent Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Quadrivalent Flu Vaccine Sales by Type (2018-2023) & (K Doses)
Table 83. Asia Quadrivalent Flu Vaccine Sales by Type (2024-2029) & (K Doses)
Table 84. Asia Quadrivalent Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 85. Asia Quadrivalent Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Quadrivalent Flu Vaccine Sales by Application (2018-2023) & (K Doses)
Table 87. Asia Quadrivalent Flu Vaccine Sales by Application (2024-2029) & (K Doses)
Table 88. Asia Quadrivalent Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 89. Asia Quadrivalent Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Quadrivalent Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Quadrivalent Flu Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 92. Asia Quadrivalent Flu Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Quadrivalent Flu Vaccine Sales by Region (2018-2023) & (K Doses)
Table 94. Asia Quadrivalent Flu Vaccine Sales by Region (2024-2029) & (K Doses)
Table 95. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Type (2018-2023) & (K Doses)
Table 96. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Type (2024-2029) & (K Doses)
Table 97. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 98. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Application (2018-2023) & (K Doses)
Table 100. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Application (2024-2029) & (K Doses)
Table 101. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Country (2018-2023) & (K Doses)
Table 107. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales by Country (2024-2029) & (K Doses)
Table 108. Sanofi Pasteur Company Information
Table 109. Sanofi Pasteur Description and Major Businesses
Table 110. Sanofi Pasteur Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 111. Sanofi Pasteur Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Sanofi Pasteur Recent Developments
Table 113. AstraZeneca Company Information
Table 114. AstraZeneca Description and Major Businesses
Table 115. AstraZeneca Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 116. AstraZeneca Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. AstraZeneca Recent Developments
Table 118. CSL Company Information
Table 119. CSL Description and Major Businesses
Table 120. CSL Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 121. CSL Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. CSL Recent Developments
Table 123. Abbott Company Information
Table 124. Abbott Description and Major Businesses
Table 125. Abbott Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 126. Abbott Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Abbott Recent Developments
Table 128. GlaxoSmithKline Company Information
Table 129. GlaxoSmithKline Description and Major Businesses
Table 130. GlaxoSmithKline Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 131. GlaxoSmithKline Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. GlaxoSmithKline Recent Developments
Table 133. Key Raw Materials Lists
Table 134. Raw Materials Key Suppliers Lists
Table 135. Quadrivalent Flu Vaccine Distributors List
Table 136. Quadrivalent Flu Vaccine Customers List
Table 137. Quadrivalent Flu Vaccine Market Trends
Table 138. Quadrivalent Flu Vaccine Market Drivers
Table 139. Quadrivalent Flu Vaccine Market Challenges
Table 140. Quadrivalent Flu Vaccine Market Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Quadrivalent Flu Vaccine Product Picture
Figure 2. Global Quadrivalent Flu Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Quadrivalent Flu Vaccine Market Share by Type in 2022 & 2029
Figure 4. Intramuscular Injection Product Picture
Figure 5. Nasal Spray Product Picture
Figure 6. Intradermal Shot Product Picture
Figure 7. Global Quadrivalent Flu Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Quadrivalent Flu Vaccine Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Public Health Agency
Figure 12. Other
Figure 13. Quadrivalent Flu Vaccine Report Years Considered
Figure 14. Global Quadrivalent Flu Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Quadrivalent Flu Vaccine Revenue 2018-2029 (US$ Million)
Figure 16. Global Quadrivalent Flu Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Quadrivalent Flu Vaccine Revenue Market Share by Region (2018-2029)
Figure 18. Global Quadrivalent Flu Vaccine Sales 2018-2029 ((K Doses)
Figure 19. Global Quadrivalent Flu Vaccine Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Quadrivalent Flu Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 21. US & Canada Quadrivalent Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Quadrivalent Flu Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 23. Europe Quadrivalent Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Quadrivalent Flu Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 25. China Quadrivalent Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Quadrivalent Flu Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 27. Asia (excluding China) Quadrivalent Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 29. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Quadrivalent Flu Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Quadrivalent Flu Vaccine in the World: Market Share by Quadrivalent Flu Vaccine Revenue in 2022
Figure 32. Global Quadrivalent Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Quadrivalent Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 34. Global Quadrivalent Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 35. Global Quadrivalent Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 36. Global Quadrivalent Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Quadrivalent Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Quadrivalent Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Quadrivalent Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Quadrivalent Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Quadrivalent Flu Vaccine Revenue Share by Country (2018-2029)
Figure 42. US & Canada Quadrivalent Flu Vaccine Sales Share by Country (2018-2029)
Figure 43. U.S. Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Quadrivalent Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 46. Europe Quadrivalent Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 47. Europe Quadrivalent Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 48. Europe Quadrivalent Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 49. Europe Quadrivalent Flu Vaccine Revenue Share by Country (2018-2029)
Figure 50. Europe Quadrivalent Flu Vaccine Sales Share by Country (2018-2029)
Figure 51. Germany Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. France Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 56. China Quadrivalent Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 57. China Quadrivalent Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 58. China Quadrivalent Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 59. China Quadrivalent Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 60. Asia Quadrivalent Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 61. Asia Quadrivalent Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 62. Asia Quadrivalent Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 63. Asia Quadrivalent Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 64. Asia Quadrivalent Flu Vaccine Revenue Share by Region (2018-2029)
Figure 65. Asia Quadrivalent Flu Vaccine Sales Share by Region (2018-2029)
Figure 66. Japan Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 70. India Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales Share by Country (2018-2029)
Figure 77. Brazil Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 82. Quadrivalent Flu Vaccine Value Chain
Figure 83. Quadrivalent Flu Vaccine Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
Figure 1. Quadrivalent Flu Vaccine Product Picture
Figure 2. Global Quadrivalent Flu Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Quadrivalent Flu Vaccine Market Share by Type in 2022 & 2029
Figure 4. Intramuscular Injection Product Picture
Figure 5. Nasal Spray Product Picture
Figure 6. Intradermal Shot Product Picture
Figure 7. Global Quadrivalent Flu Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Quadrivalent Flu Vaccine Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Public Health Agency
Figure 12. Other
Figure 13. Quadrivalent Flu Vaccine Report Years Considered
Figure 14. Global Quadrivalent Flu Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Quadrivalent Flu Vaccine Revenue 2018-2029 (US$ Million)
Figure 16. Global Quadrivalent Flu Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Quadrivalent Flu Vaccine Revenue Market Share by Region (2018-2029)
Figure 18. Global Quadrivalent Flu Vaccine Sales 2018-2029 ((K Doses)
Figure 19. Global Quadrivalent Flu Vaccine Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Quadrivalent Flu Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 21. US & Canada Quadrivalent Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Quadrivalent Flu Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 23. Europe Quadrivalent Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Quadrivalent Flu Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 25. China Quadrivalent Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Quadrivalent Flu Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 27. Asia (excluding China) Quadrivalent Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 29. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Quadrivalent Flu Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Quadrivalent Flu Vaccine in the World: Market Share by Quadrivalent Flu Vaccine Revenue in 2022
Figure 32. Global Quadrivalent Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Quadrivalent Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 34. Global Quadrivalent Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 35. Global Quadrivalent Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 36. Global Quadrivalent Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Quadrivalent Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Quadrivalent Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Quadrivalent Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Quadrivalent Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Quadrivalent Flu Vaccine Revenue Share by Country (2018-2029)
Figure 42. US & Canada Quadrivalent Flu Vaccine Sales Share by Country (2018-2029)
Figure 43. U.S. Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Quadrivalent Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 46. Europe Quadrivalent Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 47. Europe Quadrivalent Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 48. Europe Quadrivalent Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 49. Europe Quadrivalent Flu Vaccine Revenue Share by Country (2018-2029)
Figure 50. Europe Quadrivalent Flu Vaccine Sales Share by Country (2018-2029)
Figure 51. Germany Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. France Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 56. China Quadrivalent Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 57. China Quadrivalent Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 58. China Quadrivalent Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 59. China Quadrivalent Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 60. Asia Quadrivalent Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 61. Asia Quadrivalent Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 62. Asia Quadrivalent Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 63. Asia Quadrivalent Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 64. Asia Quadrivalent Flu Vaccine Revenue Share by Region (2018-2029)
Figure 65. Asia Quadrivalent Flu Vaccine Sales Share by Region (2018-2029)
Figure 66. Japan Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 70. India Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Quadrivalent Flu Vaccine Sales Share by Country (2018-2029)
Figure 77. Brazil Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Quadrivalent Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 82. Quadrivalent Flu Vaccine Value Chain
Figure 83. Quadrivalent Flu Vaccine Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
